the skin. This opens up a number of fields of application, especially in the field of women’s urology, where, for the very first time, the problem of recurring urinary tract infections can be prevented through an external application and with no side effects known to date.

With the U-med Pad, a medical product for the prevention of urinary tract diseases, Tecuro has developed the first technological platform product that is almost market-ready. The platform is protected by patents, thus offering a long-term technological head start. The platform will lead to many additional products for the treatment of UTIs (Urinary Tract Infections) and uro-vaginal infections. Tecuro has completed all the necessary steps and milestones for series compatible production. With new technology and the external application of the U-med Pad, Tecuro is also helping to counteract the problem of growing antibiotic resistance.